1 / 49

Mucopolysaccharides

Mucopolysaccharides. Dr Derakhshandeh, PhD. Medical Genetics. Definition . A gel-like substance found in: body cells mucous secretions synovial fluids. Mucopolysaccharidoses. Genetic disorders Deficiency of enzymes necessary to breakdown mucopolysaccharides (MPS)

walda
Télécharger la présentation

Mucopolysaccharides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Mucopolysaccharides Dr Derakhshandeh, PhD Medical Genetics

  2. Definition • A gel-like substance found in: • body cells • mucous secretions • synovial fluids

  3. Mucopolysaccharidoses • Genetic disorders • Deficiency of enzymes necessary to breakdown mucopolysaccharides (MPS) • Excessive accumulation of mucopolysaccharides in body tissues

  4. Mucopolysaccharidoses • Results: • many serious physical disorders • Various genetic deformities such as: • skeletal deformities (especially of the face) • mental retardation • decreased life expectancy

  5. Examples • Hunter syndrome • Hurler syndrome • Scheie syndrome • Sanfilippo syndrome • Morquio disease • Maroteaux-Lamy syndrome

  6. Hurler syndrome type I(Alpha-L-iduronate deficiency )

  7. Hurler syndrome type I Definition • An inherited disease (AR) • Storage of abnormal quantities of this material (mucopolysaccharide) in different body tissues is responsible for the symptoms and appearance of the disease

  8. Hurler syndrome (type I)

  9. Hurler syndrome type I

  10. Mucopolysaccharidosis I (MPS I) Disease (Hurler, Hurler-Scheie, Scheie Syndromes) Key Symptom Images

  11. Causes of the Hurler syndrome • Inherited as an autosomal recessive trait • Metabolic defect: inability • The body's to make an enzyme: • lysosomal alpha-L-iduronase

  12. incidence & and risk factors • Approximately 1 in 150,000 infants are affected • Newborn infants with this defect appear normal at birth • By the end of the first year, signs of impending problems begin to develop

  13. MPS (Type I) • The children slowly develop • Coarse, thick, facial features • Prominent dark eyebrows • Progressive stiffness • Mental retardation

  14. Prevention • Genetic counseling: important for parents with a family history of Hurler syndrome • Prenatal diagnosis: • An amniocentesis in the amniotic fluid are then cultured and the a-L-iduronidase activity in the cells is determined.

  15. Symptoms • Short stature • Severe mental retardation • Thick, coarse facial features with low nasal bridge • Full lips with a thick, large tongue • Increased body hair (hirsutism)

  16. Symptoms • Umbilical hernia • Deafness • Stiffness (in joints) • Shortness of breath • Abnormal bones of spine and claw hand

  17. MPS: Signs Hepatomegaly Splenomegaly Enlarged tongue Retinal pigmentation Hip dislocation Kyphosis Heart murmurs Heart valve damage from thickening

  18. Tests that may indicate the syndrome • Increased excretion of dermatan sulfate and heparan sulfate in the urine • Absence of lysosomal alpha-L-iduronidase (in cultured fibroblasts) • Culture of cells from amniotic fluid obtained by amniocentesis for enzyme testing (prenatal testing)

  19. Tests that may indicate the syndrome • Abnormal histological staining of white blood cells called metachromasia • X-ray of the skeleten • X-ray of the spine • X-ray of the chest • ECG

  20. Hunter syndrome type II(Sulpho-idoronide sulphatase deficiency )

  21. Hunter syndrome type II

  22. Hunter syndrome type II

  23. Hunter syndrome type II(Sulpho-idoronide sulphatase deficiency ) • X-linked • Coarse, thick, facial features • Progressive stiffness • decreased mental development • Hepatomegaly (liver enlargement) • Splenomegaly (spleen enlargement) • Abnormal bone x-rays

  24. Sanfilippo syndrome type III

  25. Sanfilippo syndrome type III

  26. Sanfilippo syndrome type III

  27. Sanfilippo syndrome type III Definition • Sanfilippo syndrome is one of the hereditary mucopolysaccharide storage diseases • it is characterized by the absence of one of several enzymes • These enzymes help the body get rid of a substance normally found outside of our cells called a mucopolysaccharide • This substance is called heparan sulfate, and in Sanfilippo syndrome, large amounts of it are excreted in the urine

  28. Alternative Names Mucopolysaccharidosis type III subtypes A - B – C - D • Type IIIA: heparan sulfate sulfatase deficiency • Type IIIB: N- acety-glucos-aminidase-deficiency • Type IIID: N-acetyl-glucos-amine-6-sulfate sulfatase deficiency

  29. Sanfilippo syndromeCauses • an autosomal recessive trait • It is possibly the most common of the mucopolysaccharide storage diseases • It has a relatively late onset rather than during the first year of life

  30. Causes • Coarse, thick, facial features • Prominent dark eyebrows • Progressive stiffness • gait disturbances • speech disturbances • decreased mental development that progresses to severe mental retardation

  31. Prevention • Genetic counseling: important for prospective parents with a family history of Sanfilippo syndrome Prenatal diagnosis: • An amniocentesis in the amniotic fluid are then cultured and the enzyme activity in the cells is determined.

  32. Symptoms • Family history of Sanfilippo syndrome • May have normal growth during first few years, but final height is below average • Delayed development followed by deteriorating mental status • Deterioration of gait • Coarse facial features • Full lips • Heavy eyebrows that meet in the middle of the face above the nose • Diarrhea • Stiff joints that may not extend fully

  33. Sanfilippo syndromeSigns and tests • Hepatomegaly (liver enlargement) • Splenomegaly (spleen enlargement) • Corneas clear • Echocardiogram may show thickened heart • Abnormal bone x-rays such as thickened skull and oval vertebrae

  34. Sanfilippo syndromeSigns and tests • Seizures • mental retardation • Activities of one of the enzymes may be low in fibroblast skin cells • Urine may have increased heparan sulfate • Abnormal pathological staining character of white blood cells called metachromasia

  35. Features and Characteristics children with Sanfilippo syndrome • Occasional enlarged head • Coarse facial features • Coarse hair • Excessive hair growth • Joint stiffness

  36. Sanfilippo syndrome • Severe diarrhea or constipation • Severe hearing loss • Hyperactivity • Aggressive and destructive behavior • Poor attention • Physical aggression • Speech and language delay • Sleep disturbance • Severe intellectual impairment most often before 6 years of age • Mild growth retardation • Vision impairment

  37. Morquio syndrome Type IV

  38. Morquio syndrome Type IV Skeletal abnormality - hand

  39. Skeletal abnormality: flattened vertebrae

  40. Morquio syndrome Type IV subtypes A & B • Type IVA: Galactose-6- sulfatase deficiency • Type IVB: b-Galactosidase deficiency

  41. Features and Characteristicschildren with Morquio syndrome • Joint stiffness • Mild growth retardation • Stiff joints that may not extend fully • Without mental retardation ! • Abnormal bone x-rays • X-ray of the skeleten • X-ray of the spine • X-ray of the chest

  42. Prevention • Genetic counseling: important for prospective parents with a family history of Morquio syndrome Prenatal diagnosis: • An amniocentesis in the amniotic fluid are then cultured and the enzyme activity in the cells is determined.

  43. Maroteaux-Lamy syndrome Type V(N-Acetyl-galactose-amin-4-sulfatase (Arylsulfatase B)

  44. Maroteaux-Lamy syndrome TypeV

  45. Maroteaux-Lamy syndrome TypeV

  46. Features and CharacteristicsMaroteaux-Lamy syndrome • Coarse facial features

  47. Treatment • At the present time, there is no cure for MPS disorders. • Enzyme replacement therapy and gene therapy are the two treatments that researchers have been focusing on to eventually cure MPS diseases. • There are a number of research institutions around the world working on finding a cure for the MPS diseases including facilities in the United States, Canada, England, and Australia.

More Related